Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.
about
Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition.Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and TreatmentUltra-deep sequencing detects ovarian cancer cells in peritoneal fluid and reveals somatic TP53 mutations in noncancerous tissuesTP53 Mutations and Survival in Osteosarcoma Patients: A Meta-Analysis of Published Data.Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing.Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma.Pathogenesis and heterogeneity of ovarian cancer.Recent Advances in Understanding, Diagnosing, and Treating Ovarian Cancer.TP53 mutation-mediated genomic instability induces the evolution of chemoresistance and recurrence in epithelial ovarian cancer.Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database.The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician.Effects of Endocrine-Disrupting Chemicals and Epigenetic Modifications in Ovarian Cancer: A Review.Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.Comprehensive Analysis of Cancer-Proteogenome to Identify Biomarkers for the Early Diagnosis and Prognosis of Cancer.Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.The roles of pathology in targeted therapy of women with gynecologic cancers.The rise of genomic profiling in ovarian cancer.Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: design, development and place in therapy.Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment.Reducing the Risk of Gynecologic Cancer in Hereditary Breast Ovarian Cancer Syndrome Mutation Carriers: Moral Dilemmas and the Principle of Double EffectOxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian CancerChemokine Network and Overall Survival in Wild-Type and Mutant Ovarian Cancer
P2860
Q27333756-9B621656-B0F1-4645-BCBC-79B29CA1FE39Q28066904-A8AC68E1-F6EC-48A7-B3B3-1B18FAC994DDQ28395740-97C25248-9E00-4FDD-876C-2130358D5A11Q31103785-2BCFB288-C0BC-479C-B390-F1BC6277BB78Q36910793-3BFC62E2-3C2E-4605-A885-C4B52694CFF4Q37388203-04CC2EED-0334-4DB0-B239-4A27A8E69395Q37546692-467D3D84-3B47-4428-9434-695B3A786822Q37620476-42959E1F-92E9-40B0-A603-2407DADCA8EDQ37620902-5C286FB1-FAEB-49C8-99DC-E2DA04769E1CQ38668393-44FFC0A9-95E0-4F40-8C75-22F8DF0C7790Q38787667-CB816C16-90D8-4E24-A7AC-A5EF799C553DQ39233197-1E55E525-D78B-4F9F-90D7-AC6EDC2D2135Q39364797-2260EDE6-4EC4-4CA6-89B8-1A6E5000727CQ39636313-81C9D17B-7CBD-4492-A717-6CAFD23CC1E4Q47606195-FC8C317B-EDDF-4932-9854-97FFB6C9E0DBQ48124146-0D0333E3-510E-43E9-B0C5-104BEF9C1693Q49645276-FCD3F6AE-9D7A-44BD-B9AF-78B1B5B1D272Q50345037-D17DEB69-9275-48F3-8A55-5C7DB073384FQ55041688-67359039-26D7-42CB-91FF-5121A49A54F9Q55396890-EB0D14BF-288D-42DC-8E2A-0E637C9F6184Q57137351-9E42BA4D-B05B-4384-9F66-339EAC705153Q58723357-3E75C9DF-F911-4E96-8907-35898DA37290Q58784692-3BDCA08F-CCC7-400C-9B44-5F4DC8E7959E
P2860
Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Molecular Alterations of TP53 ...... er Genome Atlas Ovarian Study.
@ast
Molecular Alterations of TP53 ...... er Genome Atlas Ovarian Study.
@en
type
label
Molecular Alterations of TP53 ...... er Genome Atlas Ovarian Study.
@ast
Molecular Alterations of TP53 ...... er Genome Atlas Ovarian Study.
@en
prefLabel
Molecular Alterations of TP53 ...... er Genome Atlas Ovarian Study.
@ast
Molecular Alterations of TP53 ...... er Genome Atlas Ovarian Study.
@en
P2093
P2860
P1476
Molecular Alterations of TP53 ...... er Genome Atlas Ovarian Study.
@en
P2093
Charles Zaloudek
Douglas A Levine
Ie-Ming Shih
Robert J Kurman
Russell Vang
P2860
P356
10.1097/PGP.0000000000000207
P577
2015-07-10T00:00:00Z